Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation

This study has been completed.
Sponsor:
Collaborators:
Kenya Medical Research Institute
University of Nairobi
Kenyatta National Hospital
Information provided by:
University of Washington
ClinicalTrials.gov Identifier:
NCT00130910
First received: August 12, 2005
Last updated: November 13, 2007
Last verified: November 2007